US clearance expands catheter brush market potential
This article was originally published in Clinica
The US FDA has given FAS Medical the go-ahead to expand the use of its endoluminal brush from collecting biofilm samples from a central venous catheter (CVC) to removing obstructive material from the catheter's internal surface. The Sunbury on Thames, UK-based firm claims that the new 510(k) clearance will significantly increase the market potential for the product. It adds that, to its knowledge, the brush is the only product of its kind which has application in the two major post-insertion complications of CVCs - infection and occlusion.